ArticleJournal of enzyme inhibition and medicinal chemistry2020

Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights.

Ahmed Sabt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.